Department of Gynecology, The Second Affiliated Hospital Harbin Medical University, Harbin, Heilongjiang, PR China.
Department of Gynecology & Obstetrics, Daqing Oilfield General Hospital, Daqing, Heilongjiang, PR China.
Per Med. 2021 Jan;18(1):43-53. doi: 10.2217/pme-2020-0014. Epub 2020 Nov 5.
Long noncoding RNA Zinc finger nuclear transcription factor, X-box binding 1-type containing 1 antisense RNA 1 (ZFAS1) has been reported to be an oncogene in various tumors. However, the role of ZFAS1 in endometrial carcinoma (EC) are not fully determined. Here, we found ZFAS1 expression was significantly upregulated in EC patients, which was significantly associated with International Federation of Gynecology and Obstetrics stage, histological grade, myometrial invasion and poor prognosis. The loss-of-function assays showed that knockdown of ZFAS1 significantly suppressed the proliferation, G1/S transition, migration and invasion in EC cells. Moreover, knockdown of ZFAS1 obviously downregulated the expression of CDK4, Cyclin D1 and N-cadherin, but upregulated E-cadherin expression. Collectively, these results suggest that ZFAS1 might be used as potential therapeutic targets for EC treatment.
长链非编码 RNA 锌指核转录因子 X 盒结合蛋白 1 型包含 1 反义 RNA 1(ZFAS1)已被报道在各种肿瘤中是一种癌基因。然而,ZFAS1 在子宫内膜癌(EC)中的作用尚未完全确定。在这里,我们发现 ZFAS1 在 EC 患者中的表达明显上调,这与国际妇产科联合会分期、组织学分级、肌层浸润和预后不良显著相关。功能丧失实验表明,ZFAS1 的敲低显著抑制了 EC 细胞的增殖、G1/S 期转换、迁移和侵袭。此外,ZFAS1 的敲低明显下调了 CDK4、Cyclin D1 和 N-钙黏蛋白的表达,而上调了 E-钙黏蛋白的表达。总之,这些结果表明 ZFAS1 可能作为 EC 治疗的潜在治疗靶点。